Cancer Diagnostic Technologies

Assessment of Current and Emerging Technologies, and Their Potential Market Applications

Publication Date	September 2009
Publisher	Venture Planning Grp.
Product Type	Report
Pages	110
ISBN Number	not applicable
Product Code	VEP00238

Buy this product or for assistance call +44 20 7060 7474

PDF £1,020.00$1697 | €1142

FAX Order above formats by FAX

Summary

This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

Content

Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
- a. Technological Principle
- b. Radioimmunoassay (RIA)
- c. Enzyme Immunoassays (EIA)
  - Overview
  - ELISA
  - Immunofiltration
  - Particle-Membrane Capture Immunoassay
  - Enzyme Amplification
- d. Fluorescent Immunoassays
- e. Luminescence
  - Chemiluminescence
  - Bioluminescence
3. Molecular Diagnostics
- a. Technology Overview
- b. Amplification Methods
  - PCR
  - DAP-PCR
  - Immuno-PCR
  - QC-PCR
  - CAR
  - DNA
  - HPA
  - LCR
  - NASBA
  - QBR
  - SDA
  - 3 SR, and others
4. Biochips/Microarrays
5. Chromosome Analysis
- a. Chronic Myelogenous Leukemia (CML)
- b. Acute Myeloid Leukemia (AML)
- c. Acute Lymphoblastic Leukemia (ALL)
- d. Malignant Lymphomas
- Lymphoid Malignancies
- e. Chronic Lymphocytic Leukemia (CLL)
- f. Solid Cancers
- g. Chromosomal Translocation and Oncogenes
6. Microcomputers and Automation
7. Artificial Intelligence
8. Flow Cytometry
9. Biosensors
- E. Competing/Complementing Technologies
- 1. CT
- 2. MRI
- 3. NMR
- 4. PET
- 5.Photonics Spectroscopy